| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K02251932 |
| PharmacoGx | BRD-K02251932 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SF3B5 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | RTN4IP1 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | ALDOA | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | C9orf142 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | PPP2R2A | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | KAT7 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | OTUD4 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | TGFBR3L | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | NPY4R | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | SEMA3A | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
